Literature DB >> 8139871

Vaccine prevention of group B streptococcal disease.

C J Baker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8139871     DOI： 10.3928/0090-4481-19931201-05

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN： 0090-4481            Impact factor:   1.132


× No keyword cloud information.
  4 in total

Review 1.  Vaccines for tomorrow.

Authors:  S K Sood
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

2.  Identification of an immunoglobulin A binding motif located in the beta-antigen of the c protein complex of group B streptococci.

Authors:  P G Jerlström; S R Talay; P Valentin-Weigand; K N Timmis; G S Chhatwal
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha.

Authors:  C Larsson; M Stålhammar-Carlemalm; G Lindahl
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

4.  Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.

Authors:  R Bhushan; B F Anthony; C E Frasch
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.